{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:47:34Z","timestamp":1648770454404},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[1987,7,1]],"date-time":"1987-07-01T00:00:00Z","timestamp":552096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1987,7]]},"DOI":"10.1007\/bf01645863","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T18:00:58Z","timestamp":1115488858000},"page":"S158-S167","source":"Crossref","is-referenced-by-count":0,"title":["Ein vergleichender \u00dcberblick zur Kombinationstherapie: Zwei \u03b2-Laktame versus \u03b2-Laktam plus Aminoglykosid"],"prefix":"10.1007","volume":"15","author":[{"given":"P.","family":"Dejace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Klastersky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Tagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/1097-0142(197208)30:2<573::AID-CNCR2820300238>3.0.CO;2-O","volume":"30","author":"E. L. Middleman","year":"1972","unstructured":"Middleman, E. L., Watanabe, A., Kaizer, H., Bodey, G. P. Antibiotic combinations for infections in neutropenic patients. Cancer 30 (1972) 573\u2013579.","journal-title":"Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.1974.03230140019004","volume":"227","author":"J. Klastersky","year":"1974","unstructured":"Klastersky, J., Henri, A., Hensgens, C., Daneau, D. Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin. JAMA 227 (1974) 45\u201348.","journal-title":"JAMA"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/AAC.7.5.640","volume":"7","author":"J. Klastersky","year":"1975","unstructured":"Klastersky, J., Hensgens, C., Debusscher, L. Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin. Antimicrob. Agents Chemother. 7 (1975) 640\u2013645.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.10.5.837","volume":"10","author":"S. C. Schimpff","year":"1976","unstructured":"Schimpff, S. C., Landesman, S., Hahn, D. M., Standiford, H C., Forther, C. L., Young, V. M., Wiernick, P. H. Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients. Antimicrob. Agents Chemother. 10 (1976) 837\u2013844.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","volume":"137","author":"The EORTC International Antimicrobial Therapy Project Group","year":"1978","unstructured":"The EORTC International Antimicrobial Therapy Project Group Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J. Infect. Dis. 137 (1978) 14\u201329.","journal-title":"J. Infect. Dis."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","volume":"77","author":"D. J. Winston","year":"1984","unstructured":"Winston, D. J., Barnes, R. C., Ho, W. G., Young, L. S., Champlin, R. E., Gale, R. P. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am. J. Med. 77 (1984) 442\u2013450.","journal-title":"Am. J. Med."},{"key":"CR7","volume-title":"Response to infection in granulocytopenic cancer patients: aminoglycoside beta-lactam versus two beta-lactams","author":"J. H. Joshi","year":"1985","unstructured":"Joshi, J. H., De Jongh, C. A., Schimpff, S. C. Response to infection in granulocytopenic cancer patients: aminoglycoside beta-lactam versus two beta-lactams. ICAAC, Minneapolis, 1985; abstract n 240."},{"key":"CR8","volume-title":"Double beta-lactam versus an aminoglycoside plus beta-lactam combination as empiric therapy for granulocytopenic cancer patients","author":"J. Joshi","year":"1984","unstructured":"Joshi, J., Ruxer, R., Newman, K., Finley, R., Moody, M. R., Drusano, G., Tenney, J., Schimpff, S. Double beta-lactam versus an aminoglycoside plus beta-lactam combination as empiric therapy for granulocytopenic cancer patients. ICAAC, Washington, 1984; abstract n 383."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/archinte.1984.00350210078014","volume":"144","author":"V. Fainstein","year":"1984","unstructured":"Fainstein, V., Bodey, G. P., Bolivar, R., Elting, L., McCredie, K. B., Keating, M. J. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. Arch. Intern. Med. 144 (1984) 1766\u20131770.","journal-title":"Arch. Intern. Med."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0002-9343(78)90188-2","volume":"64","author":"M. Gurwith","year":"1978","unstructured":"Gurwith, M., Brunton, J. L., Lank, B., Ronald, A. R., Harding, G. K. M., McCullough, D. W. Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients. Am. J. Med. 64 (1978) 127\u2013132.","journal-title":"Am. J. Med."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-198401000-00004","volume":"287","author":"R. D. Lawson","year":"1984","unstructured":"Lawson, R. D., Gentry, L. O., Bodey, G. P., Keating, M. J., Smith, T. L. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies. Am. J. Med. Sci. 287 (1984) 16\u201323.","journal-title":"Am. J. Med. Sci."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archinte.1985.00360060149023","volume":"145","author":"R. Feld","year":"1985","unstructured":"Feld, R., Louie, T. J., Mandell, L., Bow, E. J., Robson, H. G., Chow, A., Belgh, A., Miedzinski, L., Rachlis, A., Pater, J., Willan, A. A multicenter comparative trial of tobramycin and ticarcillin versus moxalactam and ticarcillin in febrile neutropenic patients. Arch. Intern. Med. 145 (1985) 1083\u20131088.","journal-title":"Arch. Intern. Med."},{"key":"CR13","unstructured":"Colon, M., Ramirez-Ronda, C. H., Rodriguez, J., Gorbea, H., Robert, F., Velez-Garcia, E., Pacheco, E., Fernandez, A.: Comparative study of piperacillin plus amikacin with piperacillin plus cefoperazone in granulocytopenic patients with fever: initial report of an ongoing study. 14th International Congress of Chemotherapy, Kyoto 1985; abstract n P-9-109."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/147.3.585","volume":"147","author":"C. C. Sanders","year":"1983","unstructured":"Sanders, C. C. Novel resistance selected by the new expanded spectrum cephalosporins: a concern. J. Infect. Dis. 147 (1983) 585\u2013589.","journal-title":"J. Infect. Dis."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/clinids\/4.2.294","volume":"4","author":"J. Klastersky","year":"1982","unstructured":"Klastersky, J., Zinner, S. H. Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev. Infect. Dis. 4 (1982) 294\u2013301.","journal-title":"Rev. Infect. Dis."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/archinte.1981.00340130051014","volume":"141","author":"D. J. Winston","year":"1981","unstructured":"Winston, D. J., Busuttil, R. W., Kurtz, T. O., Young, L. S. Moxalactam therapy for bacterial infections. Arch. Intern. Med. 141 (1981) 1607\u20131612.","journal-title":"Arch. Intern. Med."},{"key":"CR17","unstructured":"The EORTC Antimicrobial Therapy Cooperative Group: Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob. Agents Chemother. 1986 (in press)."},{"key":"CR18","first-page":"177","volume-title":"Current clinical topics in infectious diseases","author":"L. S. Young","year":"1982","unstructured":"Young, L. S. Combination or single drug therapy for gram-negative sepsis. In: Current clinical topics in infectious diseases (Remington, J. S., Swartz, M. N. eds.), McGraw-Hill Book Co. New York 1982, pp. 177\u2013205."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(79)91169-0","volume":"66","author":"L. J. Kilton","year":"1979","unstructured":"Kilton, L. J., Fossieck, B. E., Cohen, M. H., Parker, R. H. Bacteremia due to gram-positive cocci in patients with neoplastic disease. Am. J. Med. 66 (1979) 596\u2013602.","journal-title":"Am. J. Med."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/infdis\/152.1.90","volume":"152","author":"K. A. Neftel","year":"1985","unstructured":"Neftel, K. A., Hauser, S. P., M\u00fcller, M. R. Inhibition of granulopoiesisin vivo andin vitro by beta-lactam antibiotics. J. Infect. Dis. 152 (1985) 90\u201398.","journal-title":"J. Infect. Dis."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/AAC.26.2.272","volume":"26","author":"M. A. Bertram","year":"1981","unstructured":"Bertram, M. A., Young, L. S. Imipenem antagonism of thein vitro activity of piperacillin againstPseudomonas aeruginosa. Antimicrob. Agents Chemother. 26 (1981) 272\u2013274.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jac\/14.6.667","volume":"14","author":"J. E. Brorson","year":"1984","unstructured":"Brorson, J. E., Larsson, P. Cefoxitin and imipenem (N-Formimidoyl-thienamycin) can be antagonistic to aztreonam. Letter to the Editor. J. Antimicrob. Chemother. 14 (1984) 667\u2013668.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.25.2.212","volume":"25","author":"H. R. Stutman","year":"1984","unstructured":"Stutman, H. R., Welch, D. F., Scribner, R. K., Marks, M. I. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrob. Agents Chemother. 25 (1984) 212\u2013215.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1128\/AAC.20.5.620","volume":"20","author":"M. T. Hargadon","year":"1981","unstructured":"Hargadon, M. T., Young, V. M., Schimpff, S. C., Wade, J. C., Minan, G. E. Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia. Antimicrob. Agents Chemother. 20 (1981) 620\u2013624.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.26.2.224","volume":"26","author":"Y. Laethem Van","year":"1984","unstructured":"Van Laethem, Y., Husson, M., Klastersky, J. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, againstEscherichia coli, Klebsiella pneumoniae, Serratia marcescens andPseudomonas aeruginosa. Antimicrob. Agents Chemother. 26 (1984) 224\u2013227.","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Infection"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01645863.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01645863\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01645863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T08:32:59Z","timestamp":1557217979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01645863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":25,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["BF01645863"],"URL":"https:\/\/doi.org\/10.1007\/bf01645863","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,7]]}}}